Biological Data Visualization Market Size Will Attain USD 2.3 BN by 2030

The Global Biological Data Visualization Market Size accounted for USD 589.7 million in 2021 and is estimated to achieve a market size of USD 2.3 Billion by 2030 growing at a CAGR of xx% from 2022 to 2030.

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/7293

The growing research in genomics and proteomics is one of the major market driver. Major companies in the market are focusing on strategic initiatives such as new product launches, mergers and acquisitions, and technological collaborations, to increase their share in biological data visualization market. For instance, in August 2021, DNAnexus, Inc. announced that the standards of the biomedical informatics platform outperformed the online security policy objectives outlined in the U.S. Government's recent executive order. This helped build confidence for the product among NGS end-users and assisted in managing large biomedical information with high security.

 The life-science researchers and practitioners rely on visualization techniques for solving a wide range of challenges in understanding and interpreting biological information. Rapid advancements in the raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms. Besides, the increase in the adoption Of Next-Generation Sequencing (NGS) techniques and other biological data-acquisition approaches, which generate new types and sets of data, necessitates the demand for visualization tools among researchers and scientists.

For instance, Spain has become an attractive and competitive market for NGS data analysis. In September 2020, the Government of Spain allocated USD 29.5 million for precision and genomic medicine, and data science. This investment aims to enhance the capacity of the regional health system and use scientific knowledge as a tool to embrace economic competitiveness by contributing to innovation. The total funds allocated for 2 years (2020-22) is USD 89.33 million. The segment of investment includes genomic medicine, big data health, predictive medicine, advanced and personalized therapy, and precision medicine training.

The COVID-19 pandemic resulted in increased usage of sequencing information analysis platform plays a crucial role in the detection and tracing of the virus and supported the growth of biological data visualization market. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. Furthermore, key stakeholders are undertaking various strategic initiatives, such as collaborations and licensing for collaborative efforts, to combat the disease. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach to the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

Technological advancements in analytical and business intelligence solutions coupled with rapid growth in big data and the rise in the need for faster decision-making are a few other drivers boosting the demand for visualization tools in the bioinformatics field. The sheer amount of high-dimensional biological information needs machine learning and advanced data visualization approaches so that it can be easily understandable by human experts.

On the other hand, the biological data visualization market is fragmented in nature with a substantial number of companies ranging from large global players to small mid-sized local or regional players. Some of the public key vendors operating in the market include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Becton-Dickinson and Company, and 3M.

Report Scope of the Biological Data Visualization Market

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/7293

Key Takeaways:

• By technique, sequencing is estimated to have a major market share in 2021. The large amount of information generated through sequencing needs data management solutions and platforms, resulting in high demand for tools & algorithms for biological research.
• By application, the genomic analysis segment is anticipated to have a significant share of the biological data visualization market in 2021. Certain factors such as increasing investment for the development of new platforms, a positive approach toward the adoption of analytical solutions, and technological innovations are leveraging new product launches in this application.
• By platform, Mac OS is anticipated to be the fastest growing segment in the biological data visualization market. Since the operating system has a user-friendly and simple design with better in-built security features for protecting information.
• By end-user, the academic research segment is estimated to have a majority of the market share in 2021. This is attributed to the use of next-generation sequencing (NGS), and X-ray crystallography methods during their research to implement data visualization tools. Thus, an increase in the implementation of such techniques in these facilities drives the demand for visualization tools to precisely observe their research findings in biological research. 
• North America is considered to be a dominating regional market for biological data visualization in 2021 owing to the local presence of key players in the region and a significant number of research projects related to genomic analysis and systems biology.
• A few of the key market players include Thermo Fisher Scientific, Inc, 3M, Tableau Software, LLC, QIAGEN, ZEISS International, and Oxford Instruments.

Technique Insights

The sequencing segment is projected to have a considerable market share of 37.0% in 2021. Genomic analysis is expected to witness significant growth in the near future, due to the expansion of Next-generation Sequencing (NGS) technologies. The introduction of novel NGS platforms by companies, such as Illumina, Inc. and Thermo Fisher Scientific, Inc, as well as the declining cost of sequencing, facilitates the generation of a large amount of genomic information that requires biological data visualization tools to be analyzed. 

Furthermore, the introduction of workflow management systems solutions such as Galaxy and Chipster drive demand for technological advancements in information storage and management. Demand for technologically advanced infrastructure to monitor the flow of data analysis process from information generation to preliminary analysis to higher-level analysis has increased. Constantly undergoing developments in information analysis tools for obtaining effective results is anticipated to drive the market over the forecast period.

The magnetic resonance imaging segment is estimated to have the fastest CAGR in the market. Several MRI-based tools, such as BrainVoyager, have been developed for the extraction, analysis, and visualization of brain models from MRI data. Similarly, software tools, such as Cardiac Image Modeller developed by the University of Auckland, New Zealand, are specific for cardiac image processing and analysis.

Similarly, in September 2022, Qynapse Inc. collaborated with researchers from the University of Miami Miller School of Medicine to study the impact of the SARS-Cov-2 virus on vascular contributions to dementia and cognitive impairment through AI. The subjects’ MRI, neuropsychological, clinical, and biological data is likely to be collected. Hence, the integration of MRI techniques and AI for information analysis is expected to support the growth of the biological data visualization market.

Application Insights

The application of visualization software for the visualization of cell and organism images accounted for substantial revenue share of 38.8% in 2021. The advanced microscopy technology and workflows rapidly deliver millions of images at cellular and sub-cellular levels. In addition, when the cells are labeled with dyes or antibodies facilitates the detection of proteins even at a single cell level. With these advancements, cellular phenotypes can be also quantified. The generation of 3D microscopic images further drives segment growth.

Genomic analysis is projected to witness the fastest growth during the forecasted period. The study of genomes has become digital to a larger extent by the emergence of sequencing technology and its ability to determine genomic sequences at nucleotide resolution. The recent innovations in sequencing technology provide a unique capacity for information generation. Improvements in technology are expected to influence market growth in the near future. For instance, in October 2021, a group of researchers developed CoolBox, a toolkit for visual analysis of genomics information. The toolkit is user-friendly and compatible with the Python ecosystem. CoolBox is anticipated to enable researchers to produce visualization plots and assess the information in a flexible way.  

Platform Insights

The windows segment accounted for a significant revenue share of 61.1% in 2021. Windows is an extensively used operating system among all other operating systems. Currently, around 90% of computers and laptops possess Microsoft Windows 10 globally. This operating system is widely available globally and has longer life as compared to other platforms. It has the largest software library in the world. The main advantage of using Windows is that it is a highly compatible operating system with all kinds of software used for information visualization.

Although Linux is an open source operating system when compared to MAC OS and Windows. This operating system can be easily used by users, thus increasing its usability. However, as compared to Windows, this operating system possesses a complex version structure. Due to the open-source nature of Linux, numerous Linux-based operating systems, known as distros, are introduced, which impose difficulty in choosing the appropriate version.

End-use Insights

Academic research dominated the market and accounted for the largest revenue share of 61.6% in 2021.Additionally, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increases the usage of information analysis tools. For instance, in November 2019, the National Institutes of Health (NIH) provided funding of USD 29.5 million to academic centers for a new human genome reference program. The Washington University, the European Bioinformatics Institute, and the University of California received USD 12.5 million to establish a reference center for the human genome.

Furthermore, the pharmaceutical and biotechnological companies segment is projected to be the end-user with the fastest growth rate. The ongoing partnerships among research entities with companies for the development of visualization tools and incorporation of these tools are expected to drive revenue generation considerably. For instance, in January 2022, BGI Americas Corporation announced to collaborate with Gencove to offer comprehensive sequencing solutions to the customers. The partnership includes sequencing service by BGI through DNBSEQ sequencing technology with an analysis platform by Gencove. The purpose of this partnership is to offer genomic information to the players in personalized medicines and bio-sustainability. 

Regional Insights

North America dominated the biological data visualization market with the highest share of 45.1% in 2021. Its market growth can be attributed to the developed bioinformatics framework, the increase in the adoption of several computational methods, and the widespread application of advanced sequencing technologies. A large number of academic and research organizations are involved in investigating various molecular biology approaches by applying bioinformatics tools, which is expected to propel the use of information visualization tools over the coming years.

The growth of the market in Asia Pacific is also driven by the development of public and private organizations that focus on bioinformatics, computational technologies, and big data. HKUST Big Data Institute is one such example that provides a strong leadership role in Data Science and Big Data research in Hong Kong as well as across the world by conducting educational programs and research projects in Data Science and Big Data. For instance, in September 2022, HKUST announced to collaborate with the Applied Science and Technology Research Institute (ASTRI) for research and promote the sharing of technology including big data analysis and AI, in the area of pharmaceutical R&D, Fintech, and traditional Chinese medicine (TCM) service systems.

Some of the prominent players in the Biological Data Visualization Market include:

• Thermo Fisher Scientific, Inc.
• 3M
• Tableau Software, LLC, 
• QIAGEN
• ZEISS International
• Oxford Instruments
• Olympus Corporation
• General Electric Company
• Agilent Technologies Inc.
• Clarivate 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Biological Data Visualization market

• Technique
  • Microscopy
  • Magnetic resonance imaging
  • Sequencing
  • X-ray Crystallography
  • Others
• Application
  • Cell And Organism Imaging
  • Structural Biology And Molecular Modeling
  • Genomic Analysis
  • Alignments, phylogeny, And Evolution
  • Systems Biology
• Platform
  • Windows
  • Mac OS
  • Linux
  • Others
• End-use
  • Academic Research
  • Pharma & Biotech Companies
  • Hospitals & Clinics
  • Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7293

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/